These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 3181644)
21. Green tea extract impedes dyslipidaemia and development of cardiac dysfunction in streptozotocin-diabetic rats. Anandh Babu PV; Sabitha KE; Shyamaladevi CS Clin Exp Pharmacol Physiol; 2006 Dec; 33(12):1184-9. PubMed ID: 17184499 [TBL] [Abstract][Full Text] [Related]
22. Effects of aldose reductase inhibitor sorbinil on neuroaxonal dystrophy and levels of myo-inositol and sorbitol in sympathetic autonomic ganglia of streptozocin-induced diabetic rats. Schmidt RE; Plurad SB; Sherman WR; Williamson JR; Tilton RG Diabetes; 1989 May; 38(5):569-79. PubMed ID: 2497038 [TBL] [Abstract][Full Text] [Related]
23. Myocardial performance of STZ-diabetic DOCA-hypertensive rats. Dai S; McNeill JH Am J Physiol; 1992 Dec; 263(6 Pt 2):H1798-805. PubMed ID: 1481903 [TBL] [Abstract][Full Text] [Related]
24. Slow component-a of axonal transport, nerve myo-inositol, and aldose reductase inhibition in streptozocin-diabetic rats. Tomlinson DR; Sidenius P; Larsen JR Diabetes; 1986 Apr; 35(4):398-402. PubMed ID: 2420664 [TBL] [Abstract][Full Text] [Related]
25. Improvement in cardiac function in streptozotocin-diabetic rats by salt loading. Dai S; Fraser H; Yuen VG; McNeill JH Can J Physiol Pharmacol; 1994 Nov; 72(11):1288-93. PubMed ID: 7767868 [TBL] [Abstract][Full Text] [Related]
26. Cod liver oil supplementation improves cardiovascular and metabolic abnormalities in streptozotocin diabetic rats. Ceylan-Isik A; Hünkar T; Aşan E; Kaymaz F; Ari N; Söylemezoğlu T; Renda N; Soncul H; Bali M; Karasu C; J Pharm Pharmacol; 2007 Dec; 59(12):1629-41. PubMed ID: 18053324 [TBL] [Abstract][Full Text] [Related]
27. The effect of combined inositol hexakisphosphate and inositol supplement in streptozotocin-induced type 2 diabetic rats. Foster SR; Omoruyi FO; Bustamante J; Lindo RL; Dilworth LL Int J Exp Pathol; 2016 Oct; 97(5):397-407. PubMed ID: 27921351 [TBL] [Abstract][Full Text] [Related]
28. Effects of oral zinc and magnesium supplementation on serum thyroid hormone and lipid levels in experimentally induced diabetic rats. Baydas B; Karagoz S; Meral I Biol Trace Elem Res; 2002 Sep; 88(3):247-53. PubMed ID: 12350134 [TBL] [Abstract][Full Text] [Related]
29. Ascorbic acid supplementation prevents hyperlipidemia and improves myocardial performance in streptozotocin-diabetic rats. Dai S; McNeill JH Diabetes Res Clin Pract; 1995 Jan; 27(1):11-8. PubMed ID: 7781489 [TBL] [Abstract][Full Text] [Related]
30. Investigation into the cardiac effects of spironolactone in the experimental model of type 1 diabetes. Goyal BR; Solanki N; Goyal RK; Mehta AA J Cardiovasc Pharmacol; 2009 Dec; 54(6):502-9. PubMed ID: 19738487 [TBL] [Abstract][Full Text] [Related]
31. Diurnal variations of plasma growth hormone, thyrotropin, thyroxine, and triiodothyronine in streptozotocin-diabetic and food-restricted rats. Ortiz-Caro J; González C; Jolin T Endocrinology; 1984 Dec; 115(6):2227-32. PubMed ID: 6238818 [TBL] [Abstract][Full Text] [Related]
32. Effects of simvastatin treatment on oxidant/antioxidant state and ultrastructure of diabetic rat myocardium. Ceylan A; Karasu C; Aktan F; Güven C; Can B; Ozansoy G Gen Physiol Biophys; 2003 Dec; 22(4):535-47. PubMed ID: 15113125 [TBL] [Abstract][Full Text] [Related]
33. Myo-inositol normalizes decreased sodium permeability of the blood-brain barrier in streptozotocin diabetes. Knudsen GM; Jakobsen J; Barry DI; Compton AM; Tomlinson DR Neuroscience; 1989; 29(3):773-7. PubMed ID: 2525678 [TBL] [Abstract][Full Text] [Related]
34. Cardiac function of the diabetic renovascular hypertensive rat: effects of insulin and thyroid hormone treatment. Rodgers RL; Davidoff AJ; Mariani MJ Can J Physiol Pharmacol; 1991 Mar; 69(3):346-54. PubMed ID: 2059900 [TBL] [Abstract][Full Text] [Related]
35. Dietary myo-inositol therapy in hyperglycemia-induced embryopathy. Khandelwal M; Reece EA; Wu YK; Borenstein M Teratology; 1998 Feb; 57(2):79-84. PubMed ID: 9562680 [TBL] [Abstract][Full Text] [Related]
36. Effects of free fatty acids and dichloroacetate on isolated working diabetic rat heart. Nicholl TA; Lopaschuk GD; McNeill JH Am J Physiol; 1991 Oct; 261(4 Pt 2):H1053-9. PubMed ID: 1928388 [TBL] [Abstract][Full Text] [Related]
37. Effects of probucol on impaired cardiac performance and lipid metabolism in streptozotocin-induced diabetic rats. Tada H; Oida K; Kutsumi Y; Shimada Y; Nakai T; Miyabo S J Cardiovasc Pharmacol; 1992 Aug; 20(2):179-86. PubMed ID: 1381008 [TBL] [Abstract][Full Text] [Related]
38. Effect of cyclosporine treatment on carnitine and myo-inositol in diabetic rats. Reddi AS; Jyothirmayi GN; Leevy CB; Khalil M; DeAngelis B; Frank O; Baker H Comp Biochem Physiol C Comp Pharmacol Toxicol; 1992; 101(1):151-3. PubMed ID: 1350960 [TBL] [Abstract][Full Text] [Related]
39. Impaired rat sciatic nerve sodium-potassium adenosine triphosphatase in acute streptozocin diabetes and its correction by dietary myo-inositol supplementation. Greene DA; Lattimer SA J Clin Invest; 1983 Sep; 72(3):1058-63. PubMed ID: 6309904 [TBL] [Abstract][Full Text] [Related]
40. A newly synthesised molybdenum/ascorbic acid complex alleviates some effects of cardiomyopathy in streptozocin-induced diabetic rats. MacDonald K; Bailey J; MacRory C; Friis C; Vogels CM; Broderick T; Westcott SA Drugs R D; 2006; 7(1):33-42. PubMed ID: 16620135 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]